Cancer Research

CAR T cell therapy may eliminate tumor cells missed by surgery

The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells.

From Penn Medicine News

The Jin Lab taps into a key cell for cancer research

The lab, led by Chengcheng Jin, an assistant professor of cancer biology and microbiology, is investigating how the immune system co-evolves with tumors during cancer progression.

From Penn Medicine News

Advances in cancer research

Recent research shows promise in a novel CAR T therapy after cancer relapse, and a novel treatment for multiple myeloma.

From Penn Medicine News

HPV-related cancers are on the rise in men

Recent CDC data show that roughly four of every 10 cases of HPV-induced cancer now occur in men. Penn Medicine research has found that differences in levels of a particular HPV protein may inform treatment.

From Penn Medicine News

CAR T cell therapy reaches beyond cancer

Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies.

From Penn Medicine News



Media Contact


In the News


Philadelphia Inquirer

Penn Medicine is going all in on proton therapy, a costly treatment that is unproven for most common cancers

A profile examines Penn Medicine’s commitment to the advancement of proton therapy, a new radiation cancer treatment, with remarks from James Metz and Justin E. Bekelman of the Perelman School of Medicine.

FULL STORY →



Philadelphia Inquirer

For breast cancer patients, Penn researchers are comparing costly proton therapy with standard radiation

The Perelman School of Medicine’s Justin E. Bekelman is leading a $12 million study to compare the effects of proton therapy and standard radiation treatment on breast cancer.

FULL STORY →



Nature

The race to supercharge cancer-fighting T cells

Carl June and Avery Posey of the Perelman School of Medicine discuss the progression and expansion of CAR-T cell therapies.

FULL STORY →



The Washington Post

Another Crispr first: New treatment wipes out teen’s cancer

Bruce Levine of the Perelman School of Medicine says that the latest results of Crispr gene editing in a cancer patient have showcased the best possible clinical outcome thus far.

FULL STORY →



NPR

CRISPR gene-editing may boost cancer immunotherapy, new study finds

Carl June of the Perelman School of Medicine says that off-the-shelf CAR-T cell therapies using CRISPR would be a game-changer.

FULL STORY →



CBS News

Dogs may hold key to treating cancer in humans

A study by Nicola Mason of the School of Veterinary Medicine and colleagues found that an experimental immunotherapy treatment using genetically modified listeria could extend the life expectancy of dogs with cancer.

FULL STORY →